Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | The epigenomics of myeloma

Christopher Ott • 12 Sep 2019
IMW 2019
Multiple Myeloma

Christopher Ott, PhD, Massachusetts General Hosptial, Boston, MA, discusses the epigenomics of myeloma and it’s importance in moving the field forward at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals